West Completes Sale and Transfer of the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System
West Pharmaceutical Services completed the sale and transfer of manufacturing and supply rights for its SmartDose 3.5mL On-Body Delivery System and associated facilities. The transaction closed on July 1, 2026, though the company did not disclose the financial terms or consideration received for the assets.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.